Pharnext S.C.A.

Quick facts

Phase 3 pipeline

• PXT3003 dose 1 · Neurology / Rare Genetic Disorders
  PXT3003 is a fixed-dose combination of three active pharmaceutical ingredients that work synergistically to reduce neuroinflammation and promote nerve regeneration in peripheral neuropathies.

Phase 2 pipeline

• PXT00864
• PXT3003 High Dose
• PXT3003 Intermediate Dose
• PXT3003 Low dose